Quantcast

Segasist Technologies receives funding from The Health Technology Exchange (HTX) towards support of clinical validation of its Prostate MRI software

November 26, 2010

TORONTO, Nov. 26 /PRNewswire/ – Segasist Technologies, a Canadian software
company developing contouring productivity tools for medical imaging,
has today announced the receipt of funding from The Health Technology
Exchange (HTX) towards support of clinical validation of its software,
to be conducted at the Lawson Health Research Institute and London Health Sciences Centre (London, Ontario). Experts from Sunnybrook Research Institute and Sunnybrook Health Sciences Centre will also participate in the validation process by providing input in
the form of gold standard contours.

Segasist PMR-R is a software tool developed for the purpose of processing Magnetic
Resonance Images (MRI) of the prostate. Version 1.0, released on May
17, 2010
, was created to assist researchers presently developing a role
for MRI in diagnosis, tracking and treatment of prostate cancer.
Version 1.1 released on August 24, 2010, following extensive internal
validation, continues to assist prostate MRI researchers with a variety
of improvements to the previous version. Segasist Technologies will be
releasing version 2.0 of the software at RSNA 2010.

The funding received from HTX will augment grants from other sources to enable a pre-calibrated version of Segasist PMR-R to be validated
with the ultimate goal of releasing Segasist PMR-C for clinical use
following regulatory approval.

“The purpose of the validation process will be to show that the Segasist
PMR platform offers significant time savings for clinicians performing
image segmentation and volume calculations, as well as a high level of
semi-automated contouring accuracy” explains Hamid Tizhoosh, CEO of
Segasist Technologies, “Segasist PMR is the first commercial software
of its kind providing a complete solution for segmentation and
volumetric measurements of the prostate gland in MR images.”

About The Health Technology Exchange (HTX)

From Invention through to Innovation to International Invoice, HTX supports emerging and established Ontario-based companies to
develop, produce and commercialize innovative market-leading advanced
health technologies through performance-based loans and convertible
debentures. HTX is funded by the Government of Ontario through the
Ministry of Research and Innovation. For more information visit http://www.htx.ca

About Lawson Health Research Institute

The Lawson Health Research Institute is one of the largest
hospital-based research institutes in Canada. The researchers at Lawson
focus their efforts on the development of new knowledge that can be
applied directly to patient care within the hospitals. The research at
Lawson expands the continuum of life – from birth to death – and this
is reflected in the research themes that mirror the clinical areas of
London Health Sciences Centre and St. Joseph’s Health Care, London.
Lawson has joined with its partner research and clinical institutions,
among others, the London Health Sciences Centre (LHSC), to provide core
research facilities that can be utilized by investigators in London.
Lawson has over 1,200 people including principal investigators,
researchers, technicians, support staff and trainees working at seven
sites across London. For more information visit www.lawsonresearch.com

About London Health Sciences Centre

The London Health Sciences Centre (LHSC), one of Canada’s largest
acute-care teaching hospitals, is dedicated to excellence in patient
care, teaching and research. Many national and international medical
breakthroughs have been pioneered at LHSC. The physicians and staff
number is more than 10,000 and, together, they provided care for more
than one million patients last year. For more information visit www.lhsc.on.ca

About Sunnybrook Health Sciences Centre
Sunnybrook Health Sciences Centre is inventing the future of health care
for the one million patients the hospital cares for each year through
the dedication of its more than 10,000 staff and volunteers. An
internationally recognized leader in research and education and a full
affiliation with the University of Toronto distinguishes Sunnybrook as
one of Canada’s premier academic health sciences centres. Sunnybrook
specializes in caring for Canada’s war veterans, high-risk pregnancies,
critically-ill newborns, adults and the elderly, and treating and
preventing cancer, cardiovascular disease, neurological and psychiatric
disorders, orthopaedic and arthritic conditions and traumatic injuries.
For more information about how Sunnybrook is inventing the future of
health care, visit us online at www.sunnybrook.ca

About Segasist Technologies
Segasist Technologies is a software company based in Toronto, Ontario,
Canada
focused on developing contouring productivity tools for use with
advanced visualization modalities including MR, Ultrasound, and CT. The
company’s premiere product – Segasist Segmentation Assistant software -
is designed for use in improving accuracy in delineating lesions/organs
in radiation planning and radiology. Segasist is a flexible solution;
it can be applied to a multitude of medical image types, integrated
into existing commercial visualization/planning software, or used as a
plug-in productivity tool in a clinical setting.

SOURCE Segasist Technologies


Source: newswire



comments powered by Disqus